Eva SchaeferJansen - Sanofi SA Head Relations

All Insiders . France . 
Stock . Sanofi SA . Stakeholders . Insider . Eva SchaeferJansen
SAN Stock  EUR 92.09  0.01  0.01%   

Insider

Eva SchaeferJansen is Head Relations of Sanofi SA
Phone33 1 53 77 40 00
Webhttps://www.sanofi.com

Sanofi SA Management Efficiency

The company has return on total asset (ROA) of 0.0559 % which means that it generated a profit of $0.0559 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1177 %, meaning that it generated $0.1177 on every $100 dollars invested by stockholders. Sanofi SA's management efficiency ratios could be used to measure how well Sanofi SA manages its routine affairs as well as how well it operates its assets and liabilities.
Sanofi SA has accumulated 14.86 B in total debt with debt to equity ratio (D/E) of 0.34, which is about average as compared to similar companies. Sanofi SA has a current ratio of 1.52, which is within standard range for the sector. Debt can assist Sanofi SA until it has trouble settling it off, either with new capital or with free cash flow. So, Sanofi SA's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Sanofi SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Sanofi to invest in growth at high rates of return. When we think about Sanofi SA's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Hugues FourmentrauxVinci SA
55
Christiane MullerAir Liquide SA
N/A
Francois JackowAir Liquide SA
54
Michael GraffAir Liquide SA
68
Patrick RichardVinci SA
66
Thomas BuberlAXA SA
50
Jacques ChallesLOreal SA
63
Pascal VinetAir Liquide SA
61
Aude RodriguezAir Liquide SA
N/A
Antoine VanlaeysLOreal SA
54
Ulrike DecoeneAXA SA
N/A
Alexander VollertAXA SA
54
Henri BruxellesDanone SA
58
Christophe BabuleLOreal SA
58
Nicolas HieronimusLOreal SA
59
Vismay SharmaLOreal SA
51
Vronique PenchienatiBosettaDanone SA
56
Christian LabeyrieVinci SA
67
Roberto BernardiniDanone SA
59
Gregoire MontchalinAXA SA
N/A
JeanClaude GrandLOreal SA
58
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. Sanofi was incorporated in 1994 and is headquartered in Paris, France. SANOFI operates under Drug ManufacturersGeneral classification in France and is traded on Paris Stock Exchange. It employs 99412 people. Sanofi SA (SAN) is traded on Euronext Paris in France and employs 91,573 people.

Management Performance

Return On Equity0.12
Return On Asset0.0559

Sanofi SA Leadership Team

Elected by the shareholders, the Sanofi SA's board of directors comprises two types of representatives: Sanofi SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sanofi. The board's role is to monitor Sanofi SA's management team and ensure that shareholders' interests are well served. Sanofi SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sanofi SA's outside directors are responsible for providing unbiased perspectives on the board's policies.
JeanBaptiste Chatillon, Ex CFO
Roy Papatheodorou, Gen VP
Josephine Fubara, Chief Care
Paul Hudson, CEO Director
Bruno Mnard, Chief officer
Pierre Chancel, Sr Marketing
Laurent Gilhodes, Principal Accounting
Dante Beccaria, Global VP
Eva SchaeferJansen, Head Relations
Josep Catlla, Head Communications

Sanofi Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sanofi SA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.12
Return On Asset0.0559
Profit Margin0.18 %
Operating Margin0.24 %
Current Valuation128.44 B
Shares Outstanding1.25 B
Shares Owned By Insiders11.23 %
Shares Owned By Institutions47.20 %
Price To Earning8.63 X
Price To Book1.61 X

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
GOOGAlphabet Inc Class C
GOOGAlphabet Inc Class C

Other Information on Investing in Sanofi Stock

Sanofi SA financial ratios help investors to determine whether Sanofi Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sanofi with respect to the benefits of owning Sanofi SA security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY